TWLO.NYSETwilio INC

Form 4: Twilio CEO Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Twilio CEO Khozema Shipchandler sold 12,922 shares of Class A Common Stock for over $1.3 million under a pre-arranged 10b5-1 trading plan.

Summary

  • Khozema Shipchandler, Twilio's Chief Executive Officer and a Director, reported sales of Class A Common Stock.
  • A total of 12,922 shares were sold on October 3, 2025.
  • The sales were executed under a Rule 10b5-1 trading plan established on February 24, 2025.
  • The first transaction involved 3,462 shares sold at a weighted average price of $103.3009 per share, with prices ranging from $102.80 to $103.79.
  • The second transaction involved 9,460 shares sold at a weighted average price of $104.3732 per share, with prices ranging from $103.83 to $104.74.
  • Following these transactions, Shipchandler beneficially owns 220,383 shares of Class A Common Stock, a portion of which are Restricted Stock Units (RSUs).

Sentiment

Score: 5

Explanation: A Form 4 filing reporting insider sales under a 10b5-1 plan is generally neutral as it indicates pre-planned activity rather than a reactive decision, though it does represent a reduction in insider holdings.

Stakeholder Impact

  • Shareholders will note the reduction in the CEO's direct holdings, though the sale was pre-planned under a 10b5-1 trading plan.

Key Dates

DateDescription
02/24/2025Date the 10b5-1 trading plan was established.
10/03/2025Date of Class A Common Stock transactions.
10/07/2025Date the Form 4 was signed.

Recommendation

hold

The reported transactions are routine insider sales executed under a pre-established 10b5-1 trading plan, indicating a pre-scheduled liquidity event rather than a reactive decision based on new material information. While it reduces the CEO's direct holdings, it does not inherently signal a change in the company's fundamental outlook or performance, thus a 'hold' recommendation is appropriate.

Keywords

Twilio, TWLO, Khozema Shipchandler, insider trading, Form 4, stock sale, 10b5-1 plan, CEO, director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.